SCHEMBL7975252

SCHEMBL7975252

CCc1nc(O)c2c(ncn2Cc2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
ALDH1A1 P00352 3/20 0.45
GAA P10253 2/20 0.42
KMT2A Q03164 2/20 0.41
ADORA2B P29275 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
TNF P01375 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
PARN O95453 1/20 0.40
CNOT7 Q9UIV1 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.38
HIF1A Q16665 1/20 0.38
YTHDC1 Q96MU7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973934 0.92 CYP11B1 (0.45) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7989407 0.91 HPGD (0.44) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7987782 0.90 NPC1 (0.44) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7988129 0.89 MET (0.44) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7987434 0.88 CYP11B1 (0.42) HPGDSMN1; SMN2ALDH1A1KMT2ACYP11B1
SCHEMBL7984754 0.88 SMN1; SMN2 (0.47) SMN1; SMN2GAACYP11B1CYP11B2YTHDC1
SCHEMBL8059823 0.87 MEN1 (0.45) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7987609 0.87 PDE4A (0.43) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7984526 0.87 MET (0.46) HPGDSMN1; SMN2ALDH1A1KMT2ARXFP1
SCHEMBL7985471 0.87 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed